Status:
COMPLETED
Non-Interventional Study With LYRICA (Pregabalin) In Patients With Epilepsy As Adjunctive Therapy Of Partial Seizures To Reduce Seizure Frequency
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Epilepsy
Eligibility:
All Genders
18+ years
Brief Summary
The primary efficacy parameter will be the responder rate, defined as the proportion of subjects who had at least a 50% reduction in 28 day seizure rate during the maintenance phase
Eligibility Criteria
Inclusion
- age over 18 years old, patients with epilepsia with partial seizures
- Enrollment to study is fully on physician decision in compliance with current SPC.
Exclusion
- Patient who did not meet indication according to SPC Lyrica
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
199 Patients enrolled
Trial Details
Trial ID
NCT00684424
Start Date
July 1 2008
End Date
March 1 2009
Last Update
February 10 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.